Abstract Background Among Coronavirus Disease 2019 (COVID-19) manifestations,
Olfactory (OD) and Gustatory (GD) Dysfunctions (OGD) have drawn considerable attention …

Objectives The pandemic has affected over 182 million coronavirus disease 2019 (COVID-
19) cases worldwide. Accumulated evidence indicates that anosmia is one of the significant …

A significant proportion of people infected with SARS-CoV-2 report a new onset of smell or
taste loss. The duration of the chemosensory impairment and predictive factors of recovery …

Background The COVID-19 pandemic has produced a myriad of challenges, including
identifying and treating neurological sequelae. Main body COVID-19 can cause olfactory …

Coronavirus disease 2019 (COVID-19) was reported to be associated with severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, and patients present mostly …

Background Chemosensory disorders associated with COVID-19 have been widely
discussed during the pandemic. We performed a meta-analysis to assess the risk factors for …

The coronavirus disease 2019 (COVID-19) pandemic is wreaking havoc on public-health
and economic systems worldwide. Among the several neurological symptoms of patients …

Background Covid-19 became a global pandemic in 2019. Studies have shown that
coronavirus can cause neurological symptoms, but clinical studies on its neurological …

Olfactory disorders (OD) pathogenesis, underlying conditions, and prognostic in coronavirus
disease 2019 (COVID‐19) remain partially described. ANOSVID is a retrospective study in …

Background: The COVID-19 infection is a novel virus that mainly targets the respiratory
system via specific receptors without any coronavirus-targeted therapies. Many efforts have …